Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | ERN1 | O75460 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15922982 | 0.86 | GSR (0.42) | GSRERN1CA1CA2MAPT | |
| SCHEMBL27822185 | 0.81 | GABRA1 (0.44) | GSRERN1CA1CA2MAPT | |
| SCHEMBL15151800 | 0.81 | PTGS2 (0.45) | GSRGABRA1GABRB1GABRB2GABRA5 | |
| SCHEMBL9174814 | 0.80 | ERN1 (0.56) | ERN1MAPTLMNA | |
| SCHEMBL2467528 | 0.80 | GSR (0.63) | GSRCA1CA2DHFRMAPT | |
| SCHEMBL7248031 | 0.80 | PTGS2 (0.46) | LMNAGABRA1GABRB1GABRB2GABRA5 | |
| SCHEMBL10080184 | 0.80 | GABRA1 (0.43) | GSRERN1CA1CA2MAPT | |
| SCHEMBL1121537 | 0.78 | GSR (0.61) | GSRCA1CA2DHFRMAPT | |
| SCHEMBL3965396 | 0.78 | GABRA1 (0.57) | ERN1CA1CA2TYRGABRA1 | |
| SCHEMBL310863 | 0.78 | ERN1 (0.67) | ERN1CA1CA2LMNATYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070232839-A1 | NOVEL POLYNUCLEAR POLYPHENOL COMPOUND | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232839-A1 | NOVEL POLYNUCLEAR POLYPHENOL COMPOUND | TPR, PCNA, NCOA4 | GSR 1527/4885ERN1 3435/4885CA1 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.